Looking Beyond VEGF Suppression: Optimizing the Patient Journey was held on Saturday, June 17 from 6:30 – 8:00 am ET at the 2023 COS Annual Meeting.
Our host, Dr. Wai-Ching Lam, joined by four international experts, discussed the following objectives:
- Outline the role of the Tie-2/ang pathway in DME and nAMD and how it may impact patient outcomes
- Identify the important biomarkers on structural OCT that can help predict treatment response in DME and nAMD
- Discuss real-world case presentations and when to switch patients from one agent to another
International Experts
- Shaheer Aboobaker, MD
- Toronto, ON
- Case presentations
- Diana Do, MD
- Stanford, CA
- Update on faricimab in diabetic macular edema and neovascular AMD
- Sunir Garg, MD
- Philadelphia, PA
- Emerging treatments for neovascular AMD
- SriniVas Sadda, MD
- Los Angeles, CA
- Biomarkers to help predict treatment response in DME and nAMD
